ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

3 links0 made here, not in the record6 judgments3 judges (the rules as one: Rule based)1 record change seen
GPT-6 Astra (Medium)Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.gov
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT07153055Lurbinectedin WithOsimertinib in TransformedSmall Cell Lung CancerMisty ShieldsPhase 1/Phase 2 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Oct 15 · ClinicalTrials.gov record · Version of 2026-10-15Version of 2026-10-15CONDITIONSSmall Cell Lung CarcinomaThe registry's MeSH filing›Oct 20 · GPT-6 Astra (Medium) · RightAs of now · Rule based · Main conditionMain conditionDRUGSPM 01183Entry “Lurbinectedin”, read by our na…›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedOsimertinibIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTested

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Small Cell Lung Carcinoma

From the registry record2 judgments on this link
Fit of the first condition term, from the registry to what was judged
RegistrySmall Cell Lung Carcinoma, as filedthe registry files the study under it
→judged
Main condition (R9)

All judgments on this study

WhenLinkJudgeDecisionState
Oct 15The record itselfClinicalTrials.gov recordVersion of 2026-10-15Record change
Oct 20Small Cell Lung CarcinomaGPT-6 Astra (Medium)RightCurrent
Nov 3PM 01183Claude Opus 5.5TestedCurrent
Nov 3OsimertinibClaude Opus 5.5TestedCurrent
Nov 18PM 01183Rule based · role ruleTestedAgrees
Nov 18OsimertinibRule based · role ruleTestedAgrees
As of nowSmall Cell Lung CarcinomaRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.